Bevacizumab as a second- or later-line of treatment for metastatic colorectal cancer

AIM: To determine the efficacy of bevacizumab in patients with metastatic colorectal cancer (MCRC) who have failed prior chemotherapy without bevacizumab. METHODS: Between March 2002 and June 2010, 40 patients in South Korea with MCRC who were treated with bevacizumab plus chemotherapy as a second o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Park, Lee Chun, Lee, Ho Sup, Shin, Seong Hoon, Park, Seun Ja, Park, Moo In, Oh, Sung Yong, Kwon, Hyuk Chan, Baek, Jin ho, Choi, Young Jin, Kang, Myoung Joo, Kim, Yang Soo
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Co., Limited 2012
Assuntos:
Brief Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3296985/
https://ncbi.nlm.nih.gov/pubmed/22416186
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v18.i10.1104
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados